Revolution Medicines
IPO News: Filed S-1/A: Revolution Medicines, Inc. Launches 10mm Share IPO with $14.00 - $16.00 Marketing Range
Revolution Medicines

Revolution Medicines, Inc.


Initial Filing Date:  01/17/20

Launch Date:  02/03/20

Price Range:  $14.00 - $16.00

Shares Offered (Pre-Shoe | mm):  10.0

Primary Shares (mm):  10.0

Secondary Shares (mm):  0.0

Amount Offered (@ Midpoint)(mm):  $150.0

% Secondary:  0.0%

Shares Outstanding (mm):  52.9

Market Value at Midpoint (mm):  $793.5

Offering as % of Market Value:  18.9%

Bookrunners:  JP Morgan | Cowen | Leerink | Guggenheim

Major Holders:  Third Rock Ventures | Column Group | Sanofi Research Invest

Description:  Revolutions Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, high-value frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways

Note:  Emerging Growth Company


Reference Link:  S-1/A